billing Latest news from Memorial Sloan Kettering Cancer Center on News en-us Copyright 2025 News 115 31 / /images/newswise-logo-rss.gif /articles/memorial-sloan-kettering-cancer-center-announces-new-state-of-the-art-cancer-care-pavilion-will-be-named-the-kenneth-c-griffin-pavilion-at-memorial-sloan-kettering-cancer-center/?sc=rsin /articles/memorial-sloan-kettering-cancer-center-announces-new-state-of-the-art-cancer-care-pavilion-will-be-named-the-kenneth-c-griffin-pavilion-at-memorial-sloan-kettering-cancer-center/?sc=rsin Fri, 14 Mar 2025 09:10:27 EST Memorial Sloan Kettering Cancer Center (MSK) today announced that its state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center. Memorial Sloan Kettering Cancer Center /articles/emorial-sloan-kettering-cancer-center-debuts-one-hundred-views-mural-in-collaboration-with-artist-naomi-reis-and-local-p-s-183-fifth-grade-students/?sc=rsin /articles/emorial-sloan-kettering-cancer-center-debuts-one-hundred-views-mural-in-collaboration-with-artist-naomi-reis-and-local-p-s-183-fifth-grade-students/?sc=rsin Wed, 05 Mar 2025 19:05:12 EST emorial Sloan Kettering Cancer Center (MSK) is proud to announce a new community mural, "One Hundred Views," by artist Naomi Reis. The inaugural MSK mural was created in collaboration with fifth-grade students from P.S. 183 Robert L. Stevenson Elementary School, the neighboring school on East 66th Street. Memorial Sloan Kettering Cancer Center /articles/cycle-for-survival-surpasses-400-million-raised-for-rare-cancer-research/?sc=rsin /articles/cycle-for-survival-surpasses-400-million-raised-for-rare-cancer-research/?sc=rsin Wed, 26 Feb 2025 11:00:38 EST Cycle for Survival Surpasses $400 Million Raised for Rare Cancer Research Memorial Sloan Kettering Cancer Center /articles/memorial-sloan-kettering-cancer-center-surgeon-scientist-vinod-balachandran-md-named-to-the-washington-post-next-50/?sc=rsin /articles/memorial-sloan-kettering-cancer-center-surgeon-scientist-vinod-balachandran-md-named-to-the-washington-post-next-50/?sc=rsin Tue, 11 Feb 2025 08:25:46 EST Vinod Balachandran, MD, surgeon-scientist and Director of The Olayan Center for Cancer Vaccines at Memorial Sloan Kettering Cancer Center, has been named to the inaugural edition of the Post Next 50, a list of up-and-coming changemakers shaping society in 2025. Memorial Sloan Kettering Cancer Center /articles/msk-researchers-help-to-map-the-human-virome/?sc=rsin /articles/msk-researchers-help-to-map-the-human-virome/?sc=rsin Fri, 24 Jan 2025 10:30:25 EST MSK researchers are helping to map the landscape of viruses that infect us all, and to analyze the impact they have on human health and disease. Memorial Sloan Kettering Cancer Center /articles/msk-research-highlights-january-17-2025/?sc=rsin /articles/msk-research-highlights-january-17-2025/?sc=rsin Fri, 17 Jan 2025 09:50:18 EST New research from Memorial Sloan Kettering Cancer Center (MSK) provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis of brain diseases by revealing how different parts of the brain are metabolizing nutrients; describes a new method to aid the study of rare but influential cell populations; and identifies a potential treatment for malignant peripheral nerve sheath tumors. Memorial Sloan Kettering Cancer Center /articles/kimberly-feigin-appointed-chief-of-the-breast-imaging-service/?sc=rsin /articles/kimberly-feigin-appointed-chief-of-the-breast-imaging-service/?sc=rsin Mon, 13 Jan 2025 10:00:00 EST Kimberly Feigin, MD, has been named Chief of the Breast Imaging Service within the Department of Radiology. Memorial Sloan Kettering Cancer Center /articles/why-new-precision-oncology-cancer-treatments-benefit-patients-of-some-ancestries-more-than-others/?sc=rsin /articles/why-new-precision-oncology-cancer-treatments-benefit-patients-of-some-ancestries-more-than-others/?sc=rsin Fri, 10 Jan 2025 18:35:52 EST Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes. Memorial Sloan Kettering Cancer Center /articles/new-ai-tool-uses-routine-blood-tests-to-predict-immunotherapy-response-for-many-cancers/?sc=rsin /articles/new-ai-tool-uses-routine-blood-tests-to-predict-immunotherapy-response-for-many-cancers/?sc=rsin Mon, 06 Jan 2025 17:40:07 EST Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood tests and clinical data. Memorial Sloan Kettering Cancer Center /articles/the-secret-life-of-alas1-how-a-basic-science-discovery-could-pave-the-way-for-better-sirna-therapies/?sc=rsin /articles/the-secret-life-of-alas1-how-a-basic-science-discovery-could-pave-the-way-for-better-sirna-therapies/?sc=rsin Fri, 20 Dec 2024 17:30:12 EST New findings by researchers at MSK and their collaborators at the Icahn School of Medicine point to an opportunity to improve therapies that use small RNAs to silence disease-causing genes, potentially including those involved in cancer. Memorial Sloan Kettering Cancer Center /articles/msk-research-highlights-december-18-2024/?sc=rsin /articles/msk-research-highlights-december-18-2024/?sc=rsin Wed, 18 Dec 2024 19:00:00 EST New research from Memorial Sloan Kettering Cancer Center (MSK) uncovers clues about how cells control a key DNA repair protein; develops a new method for studying gene amplifications in cancer; sheds new light on tumor suppressor genes; shows MSK-IMPACT(r) could be used for HLA genotype screening to predict response to cellular therapies; identifies a possible strategy to overcome immune evasion in ovarian cancer; and finds strong support for telemedicine visits among cancer patients. Memorial Sloan Kettering Cancer Center /articles/top-cancer-research-advances-at-msk-in-2024/?sc=rsin /articles/top-cancer-research-advances-at-msk-in-2024/?sc=rsin Tue, 17 Dec 2024 12:00:16 EST Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make strides against cancer in 2024. Laboratory research teams across the institution worked to advance the global understanding of cancer and to develop new therapies, while also making fundamental insights into human biology and disease. Memorial Sloan Kettering Cancer Center /articles/memorial-sloan-kettering-physician-scientists-develop-innovative-multimodal-machine-learning-model-that-improves-prediction-of-metastatic-breast-cancer-treatment-options/?sc=rsin /articles/memorial-sloan-kettering-physician-scientists-develop-innovative-multimodal-machine-learning-model-that-improves-prediction-of-metastatic-breast-cancer-treatment-options/?sc=rsin Fri, 13 Dec 2024 18:10:23 EST New research presented during the 2024 San Antonio Breast Cancer Symposium (SABCS) reveals a new machine learning model that could change the way metastatic breast cancer is treated in the future. By combining clinical and genomic data, physician-scientists from Memorial Sloan Kettering Cancer Center (MSK) developed a tool that could help improve predictions of how people with hormone receptor-positive, HER2-negative (HR+/HER2-) metastatic breast cancer respond to CDK4/6 inhibitors, a class of oral medications that control cell division and are often prescribed in combination with hormone therapy to treat this subset of patients. Memorial Sloan Kettering Cancer Center /articles/cancer-risk-declines-in-old-age-new-msk-research-helps-explain-why/?sc=rsin /articles/cancer-risk-declines-in-old-age-new-msk-research-helps-explain-why/?sc=rsin Wed, 04 Dec 2024 11:25:14 EST A new laboratory study provides evidence about how advanced age can be protective against cancer -- with implications for treating patients in different age groups. Memorial Sloan Kettering Cancer Center /articles/msk-awards-and-appointments-november-2024/?sc=rsin /articles/msk-awards-and-appointments-november-2024/?sc=rsin Wed, 04 Dec 2024 10:00:00 EST NEW YORK, December 4, 2024 - Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Memorial Sloan Kettering Cancer Center /articles/msk-research-highlights-november-21-2024/?sc=rsin /articles/msk-research-highlights-november-21-2024/?sc=rsin Thu, 21 Nov 2024 12:10:00 EST New research from Memorial Sloan Kettering Cancer Center (MSK)& investigates how pancreatic cancer cells regulate their genome to avoid immune attack; shows promise against glioblastoma in mouse models; and develops a new method to study cancer evolution. Memorial Sloan Kettering Cancer Center /articles/msk-research-highlights-november-6-2024/?sc=rsin /articles/msk-research-highlights-november-6-2024/?sc=rsin Wed, 06 Nov 2024 11:35:15 EST New MSK research marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health; uncovers how changes to "helper" proteins drive cancer cell survival; develops a new model for investigating lung cancer metastasis; and uses AI to improve outcome predictions in sarcoma. Memorial Sloan Kettering Cancer Center /articles/ancient-immune-defense-system-plays-an-unexpected-role-in-cancer-msk-researchers-find/?sc=rsin /articles/ancient-immune-defense-system-plays-an-unexpected-role-in-cancer-msk-researchers-find/?sc=rsin Tue, 05 Nov 2024 14:10:23 EST Along with defending against pathogens, the body's innate immune system helps to protect the stability of our genomes in unexpected ways -- ways that have important implications for the development of cancer, researchers at MSK are discovering. Memorial Sloan Kettering Cancer Center /articles/ivan-maillard-named-head-of-the-division-of-hematologic-malignancies-at-memorial-sloan-kettering-cancer-center/?sc=rsin /articles/ivan-maillard-named-head-of-the-division-of-hematologic-malignancies-at-memorial-sloan-kettering-cancer-center/?sc=rsin Mon, 04 Nov 2024 10:00:00 EST Ivan Maillard, MD, PhD, has been named Head of the Division of Hematologic Malignancies within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). Memorial Sloan Kettering Cancer Center /articles/memorial-sloan-kettering-physician-scientists-elected-to-the-prestigious-national-academy-of-medicine/?sc=rsin /articles/memorial-sloan-kettering-physician-scientists-elected-to-the-prestigious-national-academy-of-medicine/?sc=rsin Mon, 21 Oct 2024 09:30:00 EST Dr. Deb Schrag, Chair of the Department of Medicine, and Dr. Lorenz Studer, Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists worldwide. Memorial Sloan Kettering Cancer Center